ã¢ã¬ã¯ã¿ãŒç€Ÿã¯èšåºæ®µéã®ãã€ãªå»è¬åäŒæ¥ã§ãããç¥çµå€æ§çŸæ£ã®æ²»çè¬ãéçºããŠãããå瀟ã®è£œåã«ã¯ãåé åŽé åèªç¥çãã¢ã«ããã€ããŒç
ãããŒãã³ãœã³ç
ãçèçž®æ§åŽçŽ¢ç¡¬åçã®æ²»çè¬ãšããŠç¬¬IIIçžèšåºè©Šéšäžã®ããåçµã¿æãã¢ãã¯ããŒãã«æäœAL001ãããã³ã¢ã«ããã€ããŒç
ãšããŒãã³ãœã³ç
ãå«ãç¥çµå€æ§çŸæ£ã®æ²»çè¬ãšããŠç¬¬Içžèšåºè©Šéšäžã®AL101ããããå瀟ã¯ãŸããã¢ã«ããã€ããŒç
ã®æ²»çè¬ãšããŠç¬¬IIçžèšåºè©Šéšäžã®è£œååè£AL002ãããã³ã¢ã«ããã€ããŒç
ã®æ²»çè¬ãšããŠç¬¬Ibçžèšåºè©Šéšäžã®AL003ãæäŸããŠãããããã«ãéçºæ®µéã®è£œåã«ã¯ãã¢ã«ããã€ããŒç
ã®ãªã¹ã¯éºäŒåã§ããMS4A4AãæšçãšããAL044ããããå
ç«ç¥çµåŠ/å
ç«è
«çåŠã®åéã§ã¯ãADP012ãADP016ãADP017ãADP023ãADP026ãADP122ãADP009ãADP022ã®8ã€ã®åè£ããããŸããAlector, Inc.ã¯ãæäœã®ç ç©¶éçºã«é¢ããŠAdimab, LLCãšææºå¥çŽãçµãã§ãããç¥çµå€æ§çŸæ£ã®æ²»çè¬AL001ãAL101ãªã©ã®ã¢ãã¯ããŒãã«æäœã®éçºãšåååã«é¢ããŠGlaxoSmithKline plcãšæŠç¥çææºå¥çŽãçµãã§ããŸããå瀟ã¯2013幎ã«èšç«ãããã«ãªãã©ã«ãã¢å·ãµãŠã¹ãµã³ãã©ã³ã·ã¹ã³ã«æ¬ç€Ÿã眮ããŠããŸãã